These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34575438)

  • 1. Poly(lactic-co-glycolic acid) Nanoparticles Encapsulating the Prenylated Flavonoid, Xanthohumol, Protect Corneal Epithelial Cells from Dry Eye Disease-Associated Oxidative Stress.
    Ghosh AK; Thapa R; Hariani HN; Volyanyuk M; Ogle SD; Orloff KA; Ankireddy S; Lai K; Žiniauskaitė A; Stubbs EB; Kalesnykas G; Hakkarainen JJ; Langert KA; Kaja S
    Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease.
    Žiniauskaitė A; Ragauskas S; Ghosh AK; Thapa R; Roessler AE; Koulen P; Kalesnykas G; Hakkarainen JJ; Kaja S
    Ocul Surf; 2019 Apr; 17(2):257-264. PubMed ID: 30807830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFE2L2 activator RS9 protects against corneal epithelial cell damage in dry eye models.
    Matsuda Y; Machida M; Nakagami Y; Nakajima T; Azuma M
    PLoS One; 2020; 15(4):e0229421. PubMed ID: 32320433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in corneal injuries of different origin: Utilization of 3D human corneal epithelial tissue model.
    Kaluzhny Y; Kinuthia MW; Lapointe AM; Truong T; Klausner M; Hayden P
    Exp Eye Res; 2020 Jan; 190():107867. PubMed ID: 31705899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esculetin protects human corneal epithelial cells from oxidative stress through Nrf-2 signaling pathway.
    Zhang Y; An Y; He X; Zhang D; He W
    Exp Eye Res; 2021 Jan; 202():108360. PubMed ID: 33220236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of thermosensitive hydrogel of Amphotericin-B and Lactoferrin combination-loaded PLGA-PEG-PEI nanoparticles for potential eradication of ocular fungal infections:
    Elhabal SF; Ghaffar SA; Hager R; Elzohairy NA; Khalifa MM; Mohie PM; Gad RA; Omar NN; Elkomy MH; Khasawneh MA; Abdelaal N
    Int J Pharm X; 2023 Dec; 5():100174. PubMed ID: 36908304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLGA nanoparticles containing Lingzhi extracts rescue corneal epithelial cells from oxidative damage.
    Tsai IL; Tsai CY; Kuo LL; Woung LC; Ku RY; Cheng YH
    Exp Eye Res; 2021 May; 206():108539. PubMed ID: 33741324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable PLGA-Based Drug Delivery Systems for Modulating Ocular Surface Disease under Experimental Murine Dry Eye.
    Chang E; McClellan AJ; Farley WJ; Li DQ; Pflugfelder SC; De Paiva CS
    J Clin Exp Ophthalmol; 2011 Nov; 2(11):. PubMed ID: 23560247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
    Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
    Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-lipoic acid: A possible pharmacological agent for treating dry eye disease and retinopathy in diabetes.
    Ajith TA
    Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1883-1890. PubMed ID: 32621549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha Tocopherol Loaded Polymeric Nanoparticles: Preparation, Characterizations, and In Vitro Assessments Against Oxidative Stress in Spinal Cord Injury Treatment.
    Laliwala A; Daverey A; Agrawal SK; Dash AK
    AAPS PharmSciTech; 2022 Jul; 23(6):195. PubMed ID: 35831684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease.
    Guzmán M; Keitelman I; Sabbione F; Trevani AS; Giordano MN; Galletti JG
    Clin Exp Immunol; 2016 May; 184(2):248-56. PubMed ID: 26690299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells.
    Plazar J; Zegura B; Lah TT; Filipic M
    Mutat Res; 2007 Aug; 632(1-2):1-8. PubMed ID: 17590382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Alcohol Consumption Elicits Corneal Toxicity Through the Generation of Cellular Oxidative Stress.
    Ghosh AK; Čėsna R; Neverauskas D; Žiniauskaitė A; Iqbal S; Eby JM; Ragauskas S; Kaja S
    J Ocul Pharmacol Ther; 2023 Jun; 39(5):303-316. PubMed ID: 37253141
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential Efficacy of Small Molecules Dynasore and Mdivi-1 for the Treatment of Dry Eye Epitheliopathy or as a Countermeasure for Nitrogen Mustard Exposure of the Ocular Surface.
    Pan J; Pany S; Martinez-Carrasco R; Fini ME
    J Pharmacol Exp Ther; 2024 Jan; 388(2):506-517. PubMed ID: 37442618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xanthohumol protect against acetaminophen-induced hepatotoxicity via Nrf2 activation through the AMPK/Akt/GSK3β pathway.
    Zhu L; Fan X; Cao C; Li K; Hou W; Ci X
    Biomed Pharmacother; 2023 Sep; 165():115097. PubMed ID: 37406514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Situ Thermoresponsive Hydrogel Containing Resveratrol-Loaded Nanoparticles as a Localized Drug Delivery Platform for Dry Eye Disease.
    De Luca I; Di Cristo F; Conte R; Peluso G; Cerruti P; Calarco A
    Antioxidants (Basel); 2023 Apr; 12(5):. PubMed ID: 37237859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal tolerance disruption favors disease progression in an extraorbital lacrimal gland excision model of murine dry eye.
    Guzmán M; Keitelman I; Sabbione F; Trevani AS; Giordano MN; Galletti JG
    Exp Eye Res; 2016 Oct; 151():19-22. PubMed ID: 27443502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a New Ocular Surface Modulator in Restoring Epithelial Changes in an In Vitro Model of Dry Eye Syndrome.
    Barabino S; De Servi B; Aragona S; Manenti D; Meloni M
    Curr Eye Res; 2017 Mar; 42(3):358-363. PubMed ID: 27163340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.